Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
InMode ( (INMD) ) just unveiled an announcement.
InMode Ltd. is currently involved in a legal proceeding following a shareholder class action filed in February 2024, alleging false or misleading statements related to its business operations. On September 12, 2025, a court order dismissed 19 of the 24 statements in the complaint with leave to amend, and the company continues to deny wrongdoing and plans to defend itself vigorously.
The most recent analyst rating on (INMD) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on InMode stock, see the INMD Stock Forecast page.
Spark’s Take on INMD Stock
According to Spark, TipRanks’ AI Analyst, INMD is a Outperform.
InMode’s strong financial performance and attractive valuation are the primary strengths, offset by challenges highlighted in the earnings call, including reduced guidance and market difficulties in North America. Technical indicators suggest a neutral trend, contributing to a balanced overall score.
To see Spark’s full report on INMD stock, click here.
More about InMode
InMode Ltd. operates in the medical technology industry, specializing in minimally invasive aesthetic medical products. The company focuses on providing innovative solutions for the beauty and wellness market, leveraging advanced technology to deliver effective treatments.
Average Trading Volume: 1,261,573
Technical Sentiment Signal: Sell
Current Market Cap: $1.04B
See more data about INMD stock on TipRanks’ Stock Analysis page.